Privacy Policy
Signals Blog

Contributors

Categories

‘Tis the season for the 2019 Till and McCulloch Meetings

by | Dec 5, 2019

Marissa Lithopoulos is a Ph.D. Candidate in Cellular and Molecular Medicine at the University of Ottawa. She works under the supervision of Dr. Bernard Thébaud at the Ottawa Hospital Research Institute. Marissa studies how brain stem cells are impaired in neonatal...

TMM 2019: Activating women’s voices and promoting equity

by | Nov 14, 2019

This cartoon from 1988, drawn by Riana Duncan for Punch, was included in a talk titled “In Search of the Lehman Sisters: Why Your Insights are Needed,” by Shari Graydon, Founder of Informed Opinions, at a “Women in Regenerative Medicine Luncheon” at the 2019 Till...

Effective workshop structure: Exploiting the ties that bind

by | Nov 7, 2019

In October, I participated in a workshop hosted by Medicine by Design (MbD) in Toronto. The workshop was right up my alley – blood stem cells and clonal evolution – but I’ll spare the Signals readership the specific details.* Rather, today’s post focuses...

Summer by Design: Filling in the gap between academia and industry

by | Sep 18, 2019

Virginia Palomares Cabeza is a fourth-year PhD candidate at the Erasmus Medical Centre (Rotterdam, the Netherlands) and the University College Dublin (Ireland). Her interdisciplinary research focuses on investigating the immune responses of allogeneic stem cell...

Right Turn: Trend watching in biotherapeutics

by | Sep 6, 2019

The field of biotherapeutics – treatments produced by, or involving, living cells – is quickly evolving with the popularity and pursuit of new cell therapies. If you’re a student or young professional working in this space, you know this already. But how familiar are...

Business of Regenerative Medicine Conference 2019: The rundown

by | Aug 8, 2019

Matthew Mistry is a Market and Equity Analyst at CCRM, where he conducts investment diligence, market analyses, participates in company creation activities and supports strategic business development. He joined CCRM from the Ontario Bioscience Innovation Organization...